Search research articles
Contact Us
Filters
Showing results (1171-1180 of 1,256) with videos related to
Page
of 126
Sort By:
The Journal of Rheumatology
|
May 2, 2021
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis
Proton Rahman, Christopher T Ritchlin, Philip S Helliwell, et al.
Npj Antimicrobials and Resistance
|
May 17, 2024
Modelling the impact of wastewater flows and management practices on antimicrobial resistance in dairy farms
Henry Todman, Richard Helliwell, Liz King, et al.
BMJ Medicine
|
March 25, 2026
Trends and inequalities in advice and guidance versus direct referral in NHS primary care, 2015-23: population based study
Kayleigh J Mason, Kelvin P Jordan, James Bailey, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2020
Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting
Robin Waxman, Carmel Stober, Deepak R Jadon, et al.
Schizophrenia Bulletin
|
October 6, 2025
iMAgery Focused Therapy for PSychosis (iMAPS-2): An Assessor-blind Feasibility Randomized Controlled Clinical Trial
Christopher D J Taylor, Ben Helliwell, Rebecca Coleman, et al.
The Journal of Rheumatology. Supplement
|
June 2, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting
Carmel Stober, Deepak R Jadon, April W Armstrong, et al.
Lancet (London, England)
|
October 27, 2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial
Philip Mease, Laura C Coates, Philip S Helliwell, et al.
Seminars in Arthritis and Rheumatism
|
February 7, 2024
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group
Lara S Chapman, Begonya Alcacer-Pitarch, John D Pauling, et al.
Annals of the Rheumatic Diseases
|
June 5, 2026
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis
Tommy K Annfeldt, Mina N Händel, Tobias Haugegaard, et al.
The Journal of Rheumatology
|
February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting
Carmel Stober, Deepak R Jadon, April W Armstrong, et al.
Page
of 126
Search research articles
Search
Showing results (1171-1180 of 1,256) with videos related to
Sort By:
Page
of 126
The Journal of Rheumatology
|
May 2, 2021
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis
Proton Rahman, Christopher T Ritchlin, Philip S Helliwell, et al.
Npj Antimicrobials and Resistance
|
May 17, 2024
Modelling the impact of wastewater flows and management practices on antimicrobial resistance in dairy farms
Henry Todman, Richard Helliwell, Liz King, et al.
BMJ Medicine
|
March 25, 2026
Trends and inequalities in advice and guidance versus direct referral in NHS primary care, 2015-23: population based study
Kayleigh J Mason, Kelvin P Jordan, James Bailey, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2020
Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting
Robin Waxman, Carmel Stober, Deepak R Jadon, et al.
Schizophrenia Bulletin
|
October 6, 2025
iMAgery Focused Therapy for PSychosis (iMAPS-2): An Assessor-blind Feasibility Randomized Controlled Clinical Trial
Christopher D J Taylor, Ben Helliwell, Rebecca Coleman, et al.
The Journal of Rheumatology. Supplement
|
June 2, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting
Carmel Stober, Deepak R Jadon, April W Armstrong, et al.
Lancet (London, England)
|
October 27, 2018
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial
Philip Mease, Laura C Coates, Philip S Helliwell, et al.
Seminars in Arthritis and Rheumatism
|
February 7, 2024
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group
Lara S Chapman, Begonya Alcacer-Pitarch, John D Pauling, et al.
Annals of the Rheumatic Diseases
|
June 5, 2026
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis
Tommy K Annfeldt, Mina N Händel, Tobias Haugegaard, et al.
The Journal of Rheumatology
|
February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting
Carmel Stober, Deepak R Jadon, April W Armstrong, et al.
Page
of 126